MT1G contributes to suppression of thyroid carcinogenesis by inhibiting cell growth and invasiveness, and inducing cell cycle arrest and apoptosis mainly through modulating the PI3K/Akt signaling pathway and partially through regulating the Rb/E2F pathway. Here, AKT1 is linked to thyroid gland disorder.